Clinical trial
National Vaccine Adverse Event Reporting Survey to Determine the Etiology of Vaccine-Induced Injury
NCT05095844 is registered in ClinicalTrials.gov with Neuroganics LLC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- National Vaccine Adverse Event Reporting Survey to Determine the Etiology of Vaccine-Induced Injury
- Lead sponsor
- Neuroganics LLC
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- March 15, 2022
- Completion date
- April 1, 2024
- Enrollment
- 100,000 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
blood clot, corona virus infection, covid-19, genetic sequencing, guillain-barré, gwas, influenza, neuritis, thrombocytopenia, vaccine adverse reaction, vaccine or biological substance, unspecified causing adverse effects in therapeutic use, vaccine reaction, vasculitis